Evaxion’s AI technology identifies cancer vaccine targets associated with longer progression-free survival of melanoma patients in the EVX-01 Phase 1 clinical trial

vaccine - Trending on BuzzSumo 2023-06-04

Summary:

Evaxion’s AI technology identifies cancer vaccine targets associated with longer progression-free survival of melanoma patients in the EVX-01 Phase 1 clinical trial yahoo.com

Link:

https://finance.yahoo.com/news/evaxion-ai-technology-identifies-cancer-210000739.html

From feeds:

Tags:

all_vaccine

Authors:

Darla Proxy

Date tagged:

06/04/2023, 12:58

Date published:

06/03/2023, 17:00